Results 151 to 160 of about 5,449,643 (269)

A pilot study assessing art therapy as a mental health intervention for subfertile women [PDF]

, 2011
Edward G. Hughes, A. M. da Silva
openalex   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

Multimodal Rehabilitation for Advanced Cancer Pain: a Narrative Review of Emerging Nonpharmacological Strategies. [PDF]

Curr Oncol Rep
Li X, Jia F, Wu P, Wen Q.
europepmc   +1 more source

Recent advancements in metal organic framework-modified multifunctional materials for photodynamic therapy

Archana Kumari Pattnaik, Newmoon Priyadarshini, Priyanka Priyadarshini, Gobinda Chandra Behera, Kulamani Parida   +4 more
openalex   +2 more sources

Niraparib as First-Line Maintenance Therapy in Patients with Stage III Ovarian Cancer and No Visible Residual Disease: AR1ZE Real-World Study [PDF]

Dana M. Chase, Maya Hanna, Jonathan Lim, Tirza Areli Calderón Boyle, Mark A. Guinter, Madeline Richey, Khilna Patel, Jeanne M. Schilder, Jean Hurteau, Amanda Golembesky   +9 more
openalex   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Retracted: Application of Ontology Matching Algorithm Based on Linguistic Features in English Pronunciation Quality Evaluation

Occupational Therapy International, 2023
Occupational Therapy International
doaj   +1 more source

Impact of vitamin D non-reimbursement policy on therapy discontinuation in the general and rheumatic population in the Netherlands: a cross-sectional study. [PDF]

BMJ Open
Singh A, Huiskes V, van den Bemt B, van Ameijden H, Nurmohamed MT, Spijkers K, Vervloet M, Brabers AEM.   +7 more
europepmc   +1 more source

Twelve-Month Follow-up of Cognitive Behavioral Therapy for Children With Functional Abdominal Pain

, 2012
Rona L. Levy, Shelby L. Langer, Lynn S. Walker, Joan M. Romano, Dennis L. Christie, Nader N. Youssef, Melissa M. DuPen, Sheri Ballard, Jennifer S. Labus, Ericka M. Welsh, Lauren D. Feld, William E. Whitehead   +11 more
openalex   +2 more sources

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source